Fractionated stereotactic radiation therapy for vestibular schwannomas

Dosimetric factors predictive of hearing outcomes

Nathan R. Bennion, Ryan K. Nowak, Elizabeth R. Lyden, Robert Bruce Thompson, Sicong Li, Chi Lin

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Purpose: To determine dosimetric factors predictive of hearing loss in vestibular schwannoma (VS) patients treated with definitive fractionated stereotactic radiation therapy (FSRT), and to report tumor control, serviceable hearing preservation, and cranial nerve toxicities. Methods and materials: We identified 45 patients (29 men and 16 women) with unilateral sporadic VS, who underwent definitive FSRT. All patients had serviceable hearing prior to treatment, defined as Gardner-Robertson Class 1 or 2. All patients underwent an audiogram before the start of treatment and serial audiometric assessments after treatment. The median audiometric follow-up time was 35.2 months (range, 5.0-89.7 months). Patients underwent a median of 4.5 (range, 1-9) posttreatment audiograms. The ipsilateral cochlea was contoured retrospectively, and dosimetric data were used to determine factors predictive of losing serviceable hearing. The median clinical follow-up time was 29.9 months (range, 1.5-83.6 months). Results: At the time of the last audiometric follow-up, 62% of patients retained serviceable hearing. The actuarial 1-, 2-, and 3-year serviceable hearing preservation rates were 83%, 75%, and 51%, respectively. The estimated median time to loss of serviceable hearing was 42.2 months. On multivariate analysis, cochlear volume

Original languageEnglish (US)
JournalPractical Radiation Oncology
DOIs
StateAccepted/In press - Sep 8 2015

Fingerprint

Acoustic Neuroma
Hearing
Radiotherapy
Cochlea
Hearing Loss
Cranial Nerves
Therapeutics
Multivariate Analysis
Neoplasms

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging

Cite this

@article{6f6e8f98587c4bfa97f2aac394b870eb,
title = "Fractionated stereotactic radiation therapy for vestibular schwannomas: Dosimetric factors predictive of hearing outcomes",
abstract = "Purpose: To determine dosimetric factors predictive of hearing loss in vestibular schwannoma (VS) patients treated with definitive fractionated stereotactic radiation therapy (FSRT), and to report tumor control, serviceable hearing preservation, and cranial nerve toxicities. Methods and materials: We identified 45 patients (29 men and 16 women) with unilateral sporadic VS, who underwent definitive FSRT. All patients had serviceable hearing prior to treatment, defined as Gardner-Robertson Class 1 or 2. All patients underwent an audiogram before the start of treatment and serial audiometric assessments after treatment. The median audiometric follow-up time was 35.2 months (range, 5.0-89.7 months). Patients underwent a median of 4.5 (range, 1-9) posttreatment audiograms. The ipsilateral cochlea was contoured retrospectively, and dosimetric data were used to determine factors predictive of losing serviceable hearing. The median clinical follow-up time was 29.9 months (range, 1.5-83.6 months). Results: At the time of the last audiometric follow-up, 62{\%} of patients retained serviceable hearing. The actuarial 1-, 2-, and 3-year serviceable hearing preservation rates were 83{\%}, 75{\%}, and 51{\%}, respectively. The estimated median time to loss of serviceable hearing was 42.2 months. On multivariate analysis, cochlear volume",
author = "Bennion, {Nathan R.} and Nowak, {Ryan K.} and Lyden, {Elizabeth R.} and Thompson, {Robert Bruce} and Sicong Li and Chi Lin",
year = "2015",
month = "9",
day = "8",
doi = "10.1016/j.prro.2015.11.015",
language = "English (US)",
journal = "Practical Radiation Oncology",
issn = "1879-8500",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Fractionated stereotactic radiation therapy for vestibular schwannomas

T2 - Dosimetric factors predictive of hearing outcomes

AU - Bennion, Nathan R.

AU - Nowak, Ryan K.

AU - Lyden, Elizabeth R.

AU - Thompson, Robert Bruce

AU - Li, Sicong

AU - Lin, Chi

PY - 2015/9/8

Y1 - 2015/9/8

N2 - Purpose: To determine dosimetric factors predictive of hearing loss in vestibular schwannoma (VS) patients treated with definitive fractionated stereotactic radiation therapy (FSRT), and to report tumor control, serviceable hearing preservation, and cranial nerve toxicities. Methods and materials: We identified 45 patients (29 men and 16 women) with unilateral sporadic VS, who underwent definitive FSRT. All patients had serviceable hearing prior to treatment, defined as Gardner-Robertson Class 1 or 2. All patients underwent an audiogram before the start of treatment and serial audiometric assessments after treatment. The median audiometric follow-up time was 35.2 months (range, 5.0-89.7 months). Patients underwent a median of 4.5 (range, 1-9) posttreatment audiograms. The ipsilateral cochlea was contoured retrospectively, and dosimetric data were used to determine factors predictive of losing serviceable hearing. The median clinical follow-up time was 29.9 months (range, 1.5-83.6 months). Results: At the time of the last audiometric follow-up, 62% of patients retained serviceable hearing. The actuarial 1-, 2-, and 3-year serviceable hearing preservation rates were 83%, 75%, and 51%, respectively. The estimated median time to loss of serviceable hearing was 42.2 months. On multivariate analysis, cochlear volume

AB - Purpose: To determine dosimetric factors predictive of hearing loss in vestibular schwannoma (VS) patients treated with definitive fractionated stereotactic radiation therapy (FSRT), and to report tumor control, serviceable hearing preservation, and cranial nerve toxicities. Methods and materials: We identified 45 patients (29 men and 16 women) with unilateral sporadic VS, who underwent definitive FSRT. All patients had serviceable hearing prior to treatment, defined as Gardner-Robertson Class 1 or 2. All patients underwent an audiogram before the start of treatment and serial audiometric assessments after treatment. The median audiometric follow-up time was 35.2 months (range, 5.0-89.7 months). Patients underwent a median of 4.5 (range, 1-9) posttreatment audiograms. The ipsilateral cochlea was contoured retrospectively, and dosimetric data were used to determine factors predictive of losing serviceable hearing. The median clinical follow-up time was 29.9 months (range, 1.5-83.6 months). Results: At the time of the last audiometric follow-up, 62% of patients retained serviceable hearing. The actuarial 1-, 2-, and 3-year serviceable hearing preservation rates were 83%, 75%, and 51%, respectively. The estimated median time to loss of serviceable hearing was 42.2 months. On multivariate analysis, cochlear volume

UR - http://www.scopus.com/inward/record.url?scp=84959509612&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959509612&partnerID=8YFLogxK

U2 - 10.1016/j.prro.2015.11.015

DO - 10.1016/j.prro.2015.11.015

M3 - Article

JO - Practical Radiation Oncology

JF - Practical Radiation Oncology

SN - 1879-8500

ER -